High dose radioimmunotherapy in malignant lymphoma.

Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer

Volumn 141, Issue , 1996, Pages 177-182

  Eary, J F ^a   Press, O W ^a  

^a UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY CONJUGATE; CD20 ANTIGEN; MONOCLONAL ANTIBODY; RADIOACTIVE IODINE;

ARTICLE; B LYMPHOCYTE; CLINICAL TRIAL; HUMAN; IMMUNOLOGY; LYMPHOMA; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; RADIATION DOSE; RADIATION RESPONSE; RADIOIMMUNOTHERAPY; REMISSION;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD20; B-LYMPHOCYTES; DOSE-RESPONSE RELATIONSHIP, RADIATION; HUMANS; IMMUNOCONJUGATES; IODINE RADIOISOTOPES; LYMPHOMA; RADIOIMMUNOTHERAPY; RADIOTHERAPY DOSAGE; REMISSION INDUCTION;

MLCS; MLOWN;

EID: 0029715681     PISSN: 00800015     EISSN: None     Source Type: Journal    
DOI: 10.1007/978-3-642-79952-5_12     Document Type: Article

References (0)